Medicine, Hematologic Malignancies and Cellular Therapy
-
-
Administers Grant
-
14th Annual Southeastern Fellows Research Skills & Training Workshop
-
2-O, 3-O desulfated heparin for the prevention of GVHD
-
A DUAL ROLE OF INTEGRIN ALPHA-3 IN BREAST CANCER CNS METASTASIS & CHEMORESISTANCE (F31)
-
A Phase 2, Single Arm Study Evaluating the Efficacy and Safety of Idelalisib in Combination with Rituximab in Patients with Previously Untreated Chronie Lymphocytic Leukemia with 17p Deletion
-
A Phase 3, Randomized Study to Evaluate the Efficacy of Momelotimib Versus Best Available Therapy in Anemic or Thrombocytopenic Subjects with Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, or Post essential Thrombocythemia Myelofibrosis
-
A Phase I Trial of Fostamatinib before Chronic Graft-vs.-Host Disease Development after Allogeneic Stem Cell Transplantation
-
A Phase I Trial of a Bcl-2 inhibitor and a MEK inhibitor for patients with relapsed indolent B-NHL
-
A Precision Oncology Micro-Organosphere-Based Platform to Guide Multiple Myeloma Therapy
-
A Randomized Phase 2 Trial to Evaluate Prebiotic Intervention in Allogeneic Hematopoietic Stem Cell Transplantation
-
A novel therap[eutic target for radiation-induced hematological malignancies: calcium calmodulin kinase kinase 2
-
AZD9668 and Neutrophil Elastase Inhibition to Prevent Graft-versus-Host Disease
-
Advanced Development of Medical Countermeasures to Enhance Platelet Regeneration
-
B-arrestin2 and the disease course of chronic myeloid leukemia (CML)
-
BAFF Pathology: Novel Therapeutic Targets in Chronic Graft versus Host Disease
-
BAFF-Driven Targeted Immunotherapy for Patients with Leukemia
-
Biodosimetry High-Throughput Test RFP-16-100-SOL-00010
-
Breaking B-Cell Tolerance to Produce Antibodies that Eradicate Leukemias and Lymphomas
-
CELGENE MULTIPLE MYELOMA TUMOR PRACTICUM
-
CaMKK2 inhibition as an approach to increase tumor immunity in breast cancers
-
Centers for Medical Countermeasures against Radiation Consortium
-
Clinical Trial of ABC294640 in Patients with Refractory Multiple Myeloma
-
Clinical Validation and Supply of SRI Radiation Biodosimeter
-
Clinical and Genetic of Monomorphic Epitheliotropic Intestinal T Cell Lymphoma
-
Clinical characteristics, JAK2 status, and macrophage infiltration in multiple myeloma patients with marrow fibrosis
-
Clinico-Genomic Assessment of Performance Status in Elderly AML Patients
-
Cord Blood Transplantation
-
Core C: Molecular and Pathology Assessment Core
-
DABAT - DNA-sensing by AIM2 in activated B cells: novel targets to improve Allogeneic haematopoietic stem cell Transplantation
-
Defining the Rules of Breast Cancer Cell Traffic Through Bone
-
Dendritic Cell Based Vaccination for Multiple Myeloma
-
Determining the mechanism of the protective of action of STO-609, a CaMKK2 inhibitor, in acute radiation syndrome
-
Development of CaMKK2 inhibitor drug for acute radiation syndrome
-
Effects of In-Home Hematopoietic Stem Cell Transplantation on the Gut Microbiota
-
Effects of PPAR agonists on response to immunomodulatory agents in patients with multiple myeloma
-
Endothelial Cell-Derived Extracellular Vesicles Mitigate Hematopoietic Injury Following Ionizing Radiation
-
Endothelial Progenitor Cell Transplant to Accelerate Hematopoietic Recovery
-
Epidermal Growth Factor Regulates Leukemic Stem Cell Self-Renewal
-
Evaluating Effects of Age-related Microbiota Modulations in Hematopoietic Stem Cell Transplant Patients
-
Exome-wide screening for common mutations in lymphoma
-
Experimental pharmacology study in mice-Narsoplimab (OMS721)
-
FY2023 RITN Center Participation
-
Genetic and genomic signatures of long-term radiation exposure in non-human primates
-
Genetic determinants of progression in chronic lymphocytic leukemia
-
Genomic Predictors of Response in Mantle Cell Lymphoma
-
Hematopoietic Cell Therapy for Young Adults with Severe Sickle Cell Disease
-
Hematopoietic Stem Cell Transplantation Combined with CSF1 Inhibition to Attenuate the Pathogenesis of Alzheimer's Disease
-
Hematopoietic Stem Cell Transplantation for Young Adults with Sickle Cell Disease
-
Home Transplant to Preserve the Microbiota and Decrease GVHD
-
Home-based Autologous Hematopoietic Stem Cell Transplantation to Improve Outcomes and Decrease Costs
-
Identify chemical probes for CAMKK2 to target the tumor microenvironment and enhance anti-tumor immune response
-
Immune Mediated Disorders After Allogeneic HCT - Project 1
-
Improving Outcomes Assessment in cGVHD
-
Investigation of CX-01 in InVitro Pre-Clinical Models of Leukemia
-
Investigation of PI3Kdelta inhibitor activity in mouse xenograft models of pre-B acute lymphoblastic leukemia ALL
-
Marrow transplant compared to supportive care in adults with sickle cell disease
-
Marrow transplant compared to supportive care in adults with sickle cell disease
-
Mechanisms of myeloid cells dysregulation in radiation survivors
-
Microbiota-focused strategies to mitigate GVHD
-
Mitigation of radiation-induced hematopoietic toxicity by rhIL-7-hyFc
-
Molecular Pathogenesis of Monoclonal B Cell Lymphocytosis and CLL
-
NCTN Network Group Operations Center
-
National Collaborative Study of Stem Cell Transplantation for Autoimmune Disease
-
Non-Myeloablative Cord Blood Transplantation
-
Novel Approaches to Stem Cell Transplantation
-
Novel combinations to overcome resistance to histone deacetylase inhibitors in lymphoma
-
Pathological B Cells: Novel Strategies to Prevent and Treat Chronic GVHD
-
Patient-centered home-based hematopoietic stem cell transplantation
-
Personalized Prebiotics to Optimize Microbiota Metabolism and Improve Transplant Outcomes
-
Personalized prebiotics to optimize microbiota metabolism and improve transplant outcomes(F)
-
Phase 1 Trial of Panobinostat + Ruxolitnib for Relapsed/Refactory Diffused Large B Cell Lymphoma (DLBCL)
-
Plerixafor for allogeneic hematopoietic stem cell transplantation
-
Point of Care Biodosimeter
-
Predicting Treatment Futility in Refractory Diffuse Large B cell Lymphoma
-
R01 Defining and targeting a novel pathway for central nervous system leptomeningeal metastasis
-
R01: Genetic Origins of Adverse Outcomes in African Americans with Lymphoma
-
R21 Enhancing CAR T therapy in multiple myeloma
-
R21 Novel use of PI3K inhibition to prevent recurrence of B-cell acute lymphoblastic leukemia
-
RITN Agreement
-
RITN 2020
-
RITN Opportunity for Radiological Preparedness
-
Regulation of Leukemia Cell Dormancy by the Bone Marrow Microenvironment
-
Role of ErbB Receptor Signaling in Regulating Normal and Leukemic Stem Cell Fate
-
Role of Osteopontin in Induction of Leukemia Dormancy in the Bone Marrow
-
Role of SLAMF7 in Racial Disparities in t(11;14) myeloma
-
SWOG Network Group Operations Center of the NCTN
-
Same
-
Scleroderma Cyclophosphamide or Transplantation (SCOT) Trial
-
Scleroderma Cyclophosphamide or Transplantation (SCOT) Trial-Option 6
-
Skin Stem Cells in Combined Radiation Injury
-
Stopping Tyrosine Kinase Inhibitors in CML Patients (Stop-TKIs)
-
Studying the Effects of Combined E-Selectin/CXCR4 Inhibition on Breast Cancer Cell Metastasis, Growth and Immune Regulation
-
Studying the Effects of Combined E-selectin and CXCR4 Inhibition on Breast Cancer Cell Immune Recognition
-
T32 UNC - Duke Immunotherapy Training Program
-
THIOREDOXIN REGULATES P53 TRANSCRIPTION IN HEMATOPOIETIC STEM CELLS
-
Targeting Beta-arrestins in myeloid malignancies
-
Targeting Dormant Breast Cancer Micrometastases to Prevent Disease Relapse
-
Targeting Histone Methylation in PTCL
-
Targeting beta-arrestins in myeloid malignancies
-
Targeting sphingosine kinase 2 for the treatment of multiple myeloma
-
The Effects of Syk Blockade with GS-9973 on Immunity in a Murine Model of GVHD
-
The Notch2-BCR Axis: Targeting Drivers of B cell Fate in Chronic GVHD
-
The Tumor Suppressive Role of ID3 in Burkitt Lymphoma
-
The genetics of hepatosplenic T cell lymphoma
-
Thioredoxin for radioprotection
-
Thioredoxin, a novel agent for mitigating radiation-induced hematopoietic injury
-
U01 RPPR: Mitigators of Radiation-Induced Endovascular Injury: Targeting Tie2 and Thrombocytopenia
-
Understanding Aberrant TLR7 Signaling in B Cells from Patients with Chronic GVHD
-
Understanding the Context-Dependent Roles of Mutations in Lymphoma
-
Understanding the context-dependent roles of mutations in lymphoma